 | • レポートコード：MRC2-11QY04247 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医薬品連続製造のグローバル市場について調査・分析したレポートです。種類別（医薬品有効成分、生物製剤、乾燥粉末）市場規模、用途別（製薬会社、契約製造組織）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医薬品連続製造の競争状況、市場シェア ・世界の医薬品連続製造市場：種類別市場規模 2015年-2020年（医薬品有効成分、生物製剤、乾燥粉末） ・世界の医薬品連続製造市場：種類別市場規模予測 2021年-2026年（医薬品有効成分、生物製剤、乾燥粉末） ・世界の医薬品連続製造市場：用途別市場規模 2015年-2020年（製薬会社、契約製造組織） ・世界の医薬品連続製造市場：用途別市場規模予測 2021年-2026年（製薬会社、契約製造組織） ・北米の医薬品連続製造市場分析：米国、カナダ ・ヨーロッパの医薬品連続製造市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医薬品連続製造市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医薬品連続製造市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医薬品連続製造市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Siemens、Corning Life Sciences、GEA Group、S K Biotek、Scott Equipment Company、Korsch、Continuus Pharmaceuticals、Chemtrix ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This in turn serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption.
Market Analysis and Insights: Global Pharmaceutical Continuous Manufacturing Market
The global Pharmaceutical Continuous Manufacturing market size is projected to reach US$ 1877.1 million by 2026, from US$ 1781 million in 2020, at a CAGR of 5.0%% during 2021-2026.
Global Pharmaceutical Continuous Manufacturing Scope and Market Size
Pharmaceutical Continuous Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Continuous Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Siemens
Corning Life Sciences
GEA Group
S K Biotek
Scott Equipment Company
Korsch
Continuus Pharmaceuticals
Chemtrix
Market segment by Type, the product can be split into
Active Pharmaceutical Ingredient
Biologics
Dry Powders
Market segment by Application, split into
Pharmaceutical Companies
Contract Manufacturing Organization
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Continuous Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Pharmaceutical Continuous Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Active Pharmaceutical Ingredient
1.4.3 Biologics
1.4.4 Dry Powders
1.5 Market by Application
1.5.1 Global Pharmaceutical Continuous Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Companies
1.5.3 Contract Manufacturing Organization
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Continuous Manufacturing Market Perspective (2015-2026)
2.2 Global Pharmaceutical Continuous Manufacturing Growth Trends by Regions
2.2.1 Pharmaceutical Continuous Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutical Continuous Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutical Continuous Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceutical Continuous Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutical Continuous Manufacturing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Continuous Manufacturing Players by Market Size
3.1.1 Global Top Pharmaceutical Continuous Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutical Continuous Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio
3.2.1 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Continuous Manufacturing Revenue in 2019
3.3 Pharmaceutical Continuous Manufacturing Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Continuous Manufacturing Product Solution and Service
3.5 Date of Enter into Pharmaceutical Continuous Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pharmaceutical Continuous Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
6.2 Pharmaceutical Continuous Manufacturing Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
7.2 Pharmaceutical Continuous Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
8 China
8.1 China Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
8.2 Pharmaceutical Continuous Manufacturing Key Players in China (2019-2020)
8.3 China Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
8.4 China Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
9.2 Pharmaceutical Continuous Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
10.2 Pharmaceutical Continuous Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
11 India
11.1 India Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
11.2 Pharmaceutical Continuous Manufacturing Key Players in India (2019-2020)
11.3 India Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
11.4 India Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
12.2 Pharmaceutical Continuous Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens
13.1.1 Siemens Company Details
13.1.2 Siemens Business Overview
13.1.3 Siemens Pharmaceutical Continuous Manufacturing Introduction
13.1.4 Siemens Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020))
13.1.5 Siemens Recent Development
13.2 Corning Life Sciences
13.2.1 Corning Life Sciences Company Details
13.2.2 Corning Life Sciences Business Overview
13.2.3 Corning Life Sciences Pharmaceutical Continuous Manufacturing Introduction
13.2.4 Corning Life Sciences Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.2.5 Corning Life Sciences Recent Development
13.3 GEA Group
13.3.1 GEA Group Company Details
13.3.2 GEA Group Business Overview
13.3.3 GEA Group Pharmaceutical Continuous Manufacturing Introduction
13.3.4 GEA Group Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.3.5 GEA Group Recent Development
13.4 S K Biotek
13.4.1 S K Biotek Company Details
13.4.2 S K Biotek Business Overview
13.4.3 S K Biotek Pharmaceutical Continuous Manufacturing Introduction
13.4.4 S K Biotek Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.4.5 S K Biotek Recent Development
13.5 Scott Equipment Company
13.5.1 Scott Equipment Company Company Details
13.5.2 Scott Equipment Company Business Overview
13.5.3 Scott Equipment Company Pharmaceutical Continuous Manufacturing Introduction
13.5.4 Scott Equipment Company Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.5.5 Scott Equipment Company Recent Development
13.6 Korsch
13.6.1 Korsch Company Details
13.6.2 Korsch Business Overview
13.6.3 Korsch Pharmaceutical Continuous Manufacturing Introduction
13.6.4 Korsch Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.6.5 Korsch Recent Development
13.7 Continuus Pharmaceuticals
13.7.1 Continuus Pharmaceuticals Company Details
13.7.2 Continuus Pharmaceuticals Business Overview
13.7.3 Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Introduction
13.7.4 Continuus Pharmaceuticals Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.7.5 Continuus Pharmaceuticals Recent Development
13.8 Chemtrix
13.8.1 Chemtrix Company Details
13.8.2 Chemtrix Business Overview
13.8.3 Chemtrix Pharmaceutical Continuous Manufacturing Introduction
13.8.4 Chemtrix Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.8.5 Chemtrix Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pharmaceutical Continuous Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutical Continuous Manufacturing Revenue
Table 3. Ranking of Global Top Pharmaceutical Continuous Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceutical Continuous Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Active Pharmaceutical Ingredient
Table 6. Key Players of Biologics
Table 7. Key Players of Dry Powders
Table 8. Global Pharmaceutical Continuous Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pharmaceutical Continuous Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pharmaceutical Continuous Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pharmaceutical Continuous Manufacturing Market Share by Regions (2015-2020)
Table 12. Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pharmaceutical Continuous Manufacturing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pharmaceutical Continuous Manufacturing Market Growth Strategy
Table 18. Main Points Interviewed from Key Pharmaceutical Continuous Manufacturing Players
Table 19. Global Pharmaceutical Continuous Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Pharmaceutical Continuous Manufacturing Market Share by Players (2015-2020)
Table 21. Global Top Pharmaceutical Continuous Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Continuous Manufacturing as of 2019)
Table 22. Global Pharmaceutical Continuous Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pharmaceutical Continuous Manufacturing Product Solution and Service
Table 25. Date of Enter into Pharmaceutical Continuous Manufacturing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Pharmaceutical Continuous Manufacturing Market Size Share by Type (2015-2020)
Table 29. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Type (2021-2026)
Table 30. Global Pharmaceutical Continuous Manufacturing Market Size Share by Application (2015-2020)
Table 31. Global Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Pharmaceutical Continuous Manufacturing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Pharmaceutical Continuous Manufacturing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Pharmaceutical Continuous Manufacturing Market Share (2019-2020)
Table 35. North America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Pharmaceutical Continuous Manufacturing Market Share by Type (2015-2020)
Table 37. North America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Pharmaceutical Continuous Manufacturing Market Share by Application (2015-2020)
Table 39. Europe Key Players Pharmaceutical Continuous Manufacturing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Pharmaceutical Continuous Manufacturing Market Share (2019-2020)
Table 41. Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Pharmaceutical Continuous Manufacturing Market Share by Type (2015-2020)
Table 43. Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Pharmaceutical Continuous Manufacturing Market Share by Application (2015-2020)
Table 45. China Key Players Pharmaceutical Continuous Manufacturing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Pharmaceutical Continuous Manufacturing Market Share (2019-2020)
Table 47. China Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 48. China Pharmaceutical Continuous Manufacturing Market Share by Type (2015-2020)
Table 49. China Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 50. China Pharmaceutical Continuous Manufacturing Market Share by Application (2015-2020)
Table 51. Japan Key Players Pharmaceutical Continuous Manufacturing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Pharmaceutical Continuous Manufacturing Market Share (2019-2020)
Table 53. Japan Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Pharmaceutical Continuous Manufacturing Market Share by Type (2015-2020)
Table 55. Japan Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Pharmaceutical Continuous Manufacturing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Pharmaceutical Continuous Manufacturing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Pharmaceutical Continuous Manufacturing Market Share (2019-2020)
Table 59. Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Pharmaceutical Continuous Manufacturing Market Share by Type (2015-2020)
Table 61. Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Pharmaceutical Continuous Manufacturing Market Share by Application (2015-2020)
Table 63. India Key Players Pharmaceutical Continuous Manufacturing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Pharmaceutical Continuous Manufacturing Market Share (2019-2020)
Table 65. India Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 66. India Pharmaceutical Continuous Manufacturing Market Share by Type (2015-2020)
Table 67. India Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 68. India Pharmaceutical Continuous Manufacturing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Pharmaceutical Continuous Manufacturing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Pharmaceutical Continuous Manufacturing Market Share (2019-2020)
Table 71. Central & South America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Pharmaceutical Continuous Manufacturing Market Share by Type (2015-2020)
Table 73. Central & South America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Pharmaceutical Continuous Manufacturing Market Share by Application (2015-2020)
Table 75. Siemens Company Details
Table 76. Siemens Business Overview
Table 77. Siemens Product
Table 78. Siemens Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 79. Siemens Recent Development
Table 80. Corning Life Sciences Company Details
Table 81. Corning Life Sciences Business Overview
Table 82. Corning Life Sciences Product
Table 83. Corning Life Sciences Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 84. Corning Life Sciences Recent Development
Table 85. GEA Group Company Details
Table 86. GEA Group Business Overview
Table 87. GEA Group Product
Table 88. GEA Group Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 89. GEA Group Recent Development
Table 90. S K Biotek Company Details
Table 91. S K Biotek Business Overview
Table 92. S K Biotek Product
Table 93. S K Biotek Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 94. S K Biotek Recent Development
Table 95. Scott Equipment Company Company Details
Table 96. Scott Equipment Company Business Overview
Table 97. Scott Equipment Company Product
Table 98. Scott Equipment Company Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 99. Scott Equipment Company Recent Development
Table 100. Korsch Company Details
Table 101. Korsch Business Overview
Table 102. Korsch Product
Table 103. Korsch Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 104. Korsch Recent Development
Table 105. Continuus Pharmaceuticals Company Details
Table 106. Continuus Pharmaceuticals Business Overview
Table 107. Continuus Pharmaceuticals Product
Table 108. Continuus Pharmaceuticals Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 109. Continuus Pharmaceuticals Recent Development
Table 110. Chemtrix Business Overview
Table 111. Chemtrix Product
Table 112. Chemtrix Company Details
Table 113. Chemtrix Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020) (Million US$)
Table 114. Chemtrix Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Continuous Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Active Pharmaceutical Ingredient Features
Figure 3. Biologics Features
Figure 4. Dry Powders Features
Figure 5. Global Pharmaceutical Continuous Manufacturing Market Share by Application: 2020 VS 2026
Figure 6. Pharmaceutical Companies Case Studies
Figure 7. Contract Manufacturing Organization Case Studies
Figure 8. Pharmaceutical Continuous Manufacturing Report Years Considered
Figure 9. Global Pharmaceutical Continuous Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pharmaceutical Continuous Manufacturing Market Share by Regions: 2020 VS 2026
Figure 11. Global Pharmaceutical Continuous Manufacturing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pharmaceutical Continuous Manufacturing Market Share by Players in 2019
Figure 14. Global Top Pharmaceutical Continuous Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Continuous Manufacturing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical Continuous Manufacturing Revenue in 2019
Figure 16. North America Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pharmaceutical Continuous Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
インスリン有効成分の世界市場（～2026年） Market Analysis and Insights: Global Insulin Active Pharmaceutical Ingredient Market The global Insulin Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Active Pharmaceutical Ing…- 継続的テストの世界市場（～2026年） The rapidly changing competitive scenarios has encouraged enterprises to adopt continuous testing to facilitate continuous delivery by continual improvement through feedback from business stakeholders, and by proper validation of processes and transactions. The Banking, Financial Services, and Insur…
- 連続繊維熱可塑性プラスチックの世界市場（～2026年） Continuous fiber thermoplastic are composites based on polycarbonate resins and an alternative to metal and other plastic composites solution. When processed into the composite tape, continuous fibers are unidirectional and run longitudinally. The factors that are playing a major role in the growth …
- 持続的腎代替療法（CRRT）の世界市場（～2026年） This Continuous Renal Replacement Therapy (CRRT) market is segmented based on product, and modality. On the basis of product, the Continuous Renal Replacement Therapy (CRRT) market is segmented into CRRT systems, disposables, and dialysates & replacement fluids, in which dialysates and replacement f…
- 高薬理活性原薬 (HPAPI)の世界市場（～2026年） The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) = 10µg/m3. Market Analysis and Insights: Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market The global High Potency Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX m…